Cerity Partners LLC Astrazeneca PLC Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

A detailed history of Cerity Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cerity Partners LLC holds 199,425 shares of AZN stock, worth $13.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
199,425
Previous 152,850 30.47%
Holding current value
$13.3 Million
Previous $11.9 Million 30.36%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$76.67 - $87.62 $3.57 Million - $4.08 Million
46,575 Added 30.47%
199,425 $15.5 Million
Q2 2024

Aug 13, 2024
SELL
$66.81 - $80.83 $3.12 Million - $3.78 Million
-46,771 Reduced 23.43%
152,850 $11.9 Million
Q1 2024

May 14, 2024
BUY
$61.03 - $69.57 $6.34 Million - $7.23 Million
103,944 Added 108.64%
199,621 $13.5 Million
Q4 2023

Jan 26, 2024
BUY
$61.89 - $69.28 $3.14 Million - $3.52 Million
50,750 Added 112.96%
95,677 $6.44 Million
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $2.21 Million - $2.45 Million
-34,128 Reduced 43.17%
44,927 $3.04 Million
Q2 2023

Aug 14, 2023
BUY
$69.91 - $75.81 $1.3 Million - $1.4 Million
18,532 Added 30.62%
79,055 $5.66 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $866,607 - $982,566
13,723 Added 29.32%
60,523 $4.2 Million
Q4 2022

Feb 15, 2023
SELL
$54.21 - $70.44 $778,943 - $1.01 Million
-14,369 Reduced 23.49%
46,800 $3.17 Million
Q3 2022

Nov 10, 2022
BUY
$53.02 - $135.75 $42,203 - $108,057
796 Added 1.32%
61,169 $3.35 Million
Q2 2022

Aug 10, 2022
BUY
$59.26 - $71.14 $1.53 Million - $1.84 Million
25,826 Added 74.76%
60,373 $3.99 Million
Q1 2022

Apr 25, 2022
BUY
$55.72 - $67.12 $603,336 - $726,775
10,828 Added 45.65%
34,547 $2.03 Million
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $657,153 - $776,491
12,165 Added 105.29%
23,719 $1.39 Million
Q3 2021

Oct 25, 2021
BUY
$55.56 - $60.79 $57,060 - $62,431
1,027 Added 9.76%
11,554 $694,000
Q2 2021

Aug 11, 2021
BUY
$48.42 - $60.18 $82,749 - $102,847
1,709 Added 19.38%
10,527 $631,000
Q1 2021

Aug 11, 2021
SELL
$47.16 - $54.44 $354,077 - $408,735
-7,508 Reduced 45.99%
8,818 $438,000
Q1 2021

May 12, 2021
SELL
$47.16 - $54.44 $65,033 - $75,072
-1,379 Reduced 7.79%
16,326 $812,000
Q4 2020

Feb 11, 2021
BUY
$48.52 - $58.02 $220,523 - $263,700
4,545 Added 34.54%
17,705 $885,000
Q3 2020

Nov 12, 2020
BUY
$53.07 - $61.1 $60,234 - $69,348
1,135 Added 9.44%
13,160 $721,000
Q2 2020

Aug 17, 2020
SELL
$43.1 - $55.31 $22,239 - $28,539
-516 Reduced 4.11%
12,025 $637,000
Q2 2020

Aug 14, 2020
SELL
$43.1 - $55.31 $42,281 - $54,259
-981 Reduced 7.25%
12,541 $664,000
Q1 2020

May 14, 2020
SELL
$37.79 - $51.33 $80,757 - $109,692
-2,137 Reduced 13.65%
13,522 $604,000
Q4 2019

Feb 14, 2020
SELL
$42.46 - $50.46 $375,643 - $446,419
-8,847 Reduced 36.1%
15,659 $780,000
Q3 2019

Oct 30, 2019
BUY
$40.12 - $45.47 $348,281 - $394,725
8,681 Added 54.86%
24,506 $1.09 Million
Q2 2019

Aug 14, 2019
SELL
$37.28 - $41.68 $781,873 - $874,154
-20,973 Reduced 56.99%
15,825 $654,000
Q1 2019

May 14, 2019
BUY
$35.49 - $43.02 $106,753 - $129,404
3,008 Added 8.9%
36,798 $1.49 Million
Q4 2018

Feb 06, 2019
SELL
$36.86 - $41.49 $15,002 - $16,886
-407 Reduced 1.19%
33,790 $1.28 Million
Q3 2018

Nov 15, 2018
SELL
$34.76 - $39.72 $21,412 - $24,467
-616 Reduced 1.77%
34,197 $1.35 Million
Q2 2018

Aug 15, 2018
BUY
$34.55 - $37.05 $401,781 - $430,854
11,629 Added 50.16%
34,813 $1.22 Million
Q1 2018

May 15, 2018
SELL
$32.97 - $36.63 $326,732 - $363,003
-9,910 Reduced 29.95%
23,184 $811,000
Q4 2017

Feb 14, 2018
BUY
$32.09 - $34.78 $375,420 - $406,891
11,699 Added 54.68%
33,094 $1.15 Million
Q3 2017

Nov 13, 2017
BUY
$28.96 - $34.0 $619,599 - $727,430
21,395
21,395 $725,000

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email